Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Russell, Patrick"" wg kryterium: Autor


Tytuł :
Durable Cr‐substituted (Ba,Cs)1.33(Cr,Ti)8O16 hollandite waste forms with high Cs loading.
Autorzy :
Zhao, Mingyang (AUTHOR)
Birkner, Nancy (AUTHOR)
Schaeperkoetter, Joseph (AUTHOR)
Koch, Robert J. (AUTHOR)
Russell, Patrick (AUTHOR)
Misture, Scott T. (AUTHOR)
Besmann, Theodore (AUTHOR)
Amoroso, Jake (AUTHOR)
Brinkman, Kyle S. (AUTHOR)
Pokaż więcej
Źródło :
Journal of the American Ceramic Society. Jun2022, Vol. 105 Issue 6, p4564-4576. 13p.
Czasopismo naukowe
Tytuł :
Preoperative polypharmacy assessment for risk stratification and management.
Autorzy :
Mangoni AA; Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia.; Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, Australia.
Russell P; Department of Internal Medicine, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, Australia.
Jarmuzewska EA; Formerly Department of Internal Medicine, Polyclinic IRCCS, Ospedale Maggiore, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 May; Vol. 88 (5), pp. 1952-1954. Date of Electronic Publication: 2022 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Polypharmacy*
Humans ; Risk Assessment
Czasopismo naukowe
Tytuł :
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern.
Autorzy :
Griffin AJ; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.
O'Donnell KL; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.
Shifflett K; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.
Lavik JP; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Russell PM; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Zimmerman MK; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Relich RF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Mar 10; Vol. 12 (1), pp. 3954. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Broadly Neutralizing Antibodies/*immunology
COVID-19/*virology
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/immunology ; Chemokines/blood ; Cytokines/blood ; Female ; Humans ; Male ; Middle Aged ; Patient Acuity ; Young Adult
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection.
Autorzy :
Li W; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Syed F; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Yu R; Department of Internal Medicine, School of Medicine, University of Nevada, Reno, NV, United States.
Yang J; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Xia Y; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.; School of Laboratory Medicine, Wenzhou Medical University, Wenzhou, China.
Relich RF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Russell PM; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Zhang S; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Khalili M; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Huang L; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Kacena MA; Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN, United States.
Zheng X; School of Laboratory Medicine, Wenzhou Medical University, Wenzhou, China.; Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Yu Q; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2022 Feb 23; Vol. 13, pp. 833310. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Alcoholism/*immunology
COVID-19/*immunology
HIV Infections/*immunology
HIV-1/*physiology
Neoplasms/*immunology
SARS-CoV-2/*physiology
Biomarkers/blood ; Humans ; Immune Checkpoint Proteins/blood ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern.
Autorzy :
Griffin AJ; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
O'Donnell KL; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Shifflett K; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Lavik JP; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Russell PM; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Zimmerman MK; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Relich RF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2021 Nov 12. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Preprint
Tytuł :
Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home.
Autorzy :
Russell P; Internal Medicine, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
Hewage U; Internal Medicine, Southern Adelaide Local Health Network, Bedford Park, SA, Australia.
McDonald C; Department of Pharmacy, Central Adelaide Local Health Network, Adelaide, SA, Australia.
Thompson C; General Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Woodman R; College of Medicine and Public Health, Flinders University, Adelaide SA, Australia.
Mangoni AA; Discipline of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Bedford Park, SA, Australia.
Pokaż więcej
Źródło :
Therapeutic advances in drug safety [Ther Adv Drug Saf] 2021 Oct 22; Vol. 12, pp. 20420986211052344. Date of Electronic Publication: 2021 Oct 22 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies